These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589 [TBL] [Abstract][Full Text] [Related]
5. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Thorne JE; Woreta FA; Jabs DA; Anhalt GJ Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554 [TBL] [Abstract][Full Text] [Related]
6. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151 [TBL] [Abstract][Full Text] [Related]
14. Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid. Shifera AS; Hong GH; Khan IR; Okeagu C; Thorne JE Am J Ophthalmol; 2021 Mar; 223():21-27. PubMed ID: 32976845 [TBL] [Abstract][Full Text] [Related]
15. Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. Friedman J; Marcovich AL; Kleinmann G; Schattner A Cornea; 2014 Oct; 33(10):1066-70. PubMed ID: 25014147 [TBL] [Abstract][Full Text] [Related]
16. Ocular Cicatricial Pemphigoid: Camouflaged as Persistent Conjunctivitis. Mughal JU; Muhammad AJ; Erum U J Coll Physicians Surg Pak; 2019 Jun; 29(6):S34-S36. PubMed ID: 31142415 [TBL] [Abstract][Full Text] [Related]
17. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy. Ahmed AR; Colón JE Arch Dermatol; 2001 Sep; 137(9):1181-9. PubMed ID: 11559214 [TBL] [Abstract][Full Text] [Related]
18. Update on ocular cicatricial pemphigoid and emerging treatments. Queisi MM; Zein M; Lamba N; Meese H; Foster CS Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362 [TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. El Darouti MA; Fakhry Khattab MA; Hegazy RA; Hafez DA; Gawdat HI Eur J Ophthalmol; 2011; 21(5):529-37. PubMed ID: 21279976 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in ocular cicatricial pemphigoid. Mondino BJ; Brown SI Am J Ophthalmol; 1983 Oct; 96(4):453-9. PubMed ID: 6353928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]